Arachidonic acid-induced gene expression in colon cancer cells.
It is well documented that arachidonic acid (AA) and its metabolites are intimately linked to cancer biology. However, the downstream mechanism(s) that link AA levels to cancer cell proliferation remain to be elucidated. Initial experiments in the current study showed that exogenous AA and inhibitors of AA metabolism that lead to the accumulation of unesterified AA are cytotoxic to the colon cancer cell line, HCT-116. Additionally, exogenous AA and triacsin C, an inhibitor of AA acylation, induced apoptosis and related caspase-3 activity in a transcriptionally dependent manner. Gene array analysis revealed that both exogenous AA and triacsin C alter the expression of similar genes in HCT-116 cells. For example, both downregulate several genes with well-documented roles in cell survival and apoptotic resistance. Conversely, both upregulate genes encoding activator protein-1 (AP-1) transcription factors, which have known roles in inducing apoptosis, and genes that counteract ras (Erk/MAPK) growth signaling pathways. Real-time polymerase chain reaction and immunoblotting demonstrated that mRNA and protein levels of one of the major AP-1 transcription factors, c-Jun, is markedly elevated by exogenous AA and triacsin C. Additionally, the cyclooxygenase inhibitor, sulindac sulfide, increases c-Jun mRNA levels. Together, these studies reveal that the generation of intracellular AA and its subsequent impact on gene expression probably represents a critical step that regulates colon cancer cell proliferation.
Monjazeb
Arta M
AM
Department of Cancer Biology, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA.
High
Kevin P
KP
Connoy
Abbie
A
Hart
Lori S
LS
Koumenis
Constantinos
C
Chilton
Floyd H
FH
D017209:Apoptosis / Q000187:drug effects; D016718:Arachidonic Acid / Q000378:metabolism / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D003110:Colonic Neoplasms / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D045325:HCT116 Cells; D006801:Humans; D016755:Proto-Oncogene Proteins c-jun / Q000502:physiology; D018808:Transcription Factor AP-1 / Q000235:genetics; D014158:Transcription, Genetic; D014226:Triazenes / Q000494:pharmacology
D016755:Proto-Oncogene Proteins c-jun; D018808:Transcription Factor AP-1; D014226:Triazenes; D016718:Arachidonic Acid; C034613:triacsin C